Skip to content

Clinical trials

Hyperoxaluria trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperoxaluria Country / region: United States Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20033
20061
20072
20091
20101
20133
20141
20153
20162
20171
20181
20192
20201
20211
20231
20243
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Recruiting7
Terminated2
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Mayo Clinic12
Allena Pharmaceuticals6
Alnylam Pharmaceuticals2
OxThera2
University of Alabama at Birmingham2
BioMarin Pharmaceutical1
Novome Biotechnologies Inc1
University of Texas Southwestern Medical Center1
University of Wisconsin, Madison1
YolTech Therapeutics Co., Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperoxaluria29
Hyperoxaluria, Primary14
Kidney Calculi13
Nephrolithiasis7
Cystinuria4
Dent Disease4
Kidney Diseases4
Urologic Diseases4
Urolithiasis2
Calculi1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.